QureTech Bio’s vision is to develop first-in -class drugs to combat infectious diseases and the occurrence of antibiotic resistance

QureTech Bio is founded on world-leading research from groups based at Umeå University, Sweden, and Washington University, St Louis, USA. Since the foundation, several key persons have joined the company either as board members, researchers, or scientific advisors.

The company has received soft funding from Umeå Biotech Incubator, the European Union Horizon 2020 program SME Instrument Phase 1, Swelife (a strategic innovation program funded by the Swedish innovation agency Vinnova), and by the ENABLE-2 program (via Vinnova).

Founders

Scott Hultgren

Fredrik Almqvist

Sven Bergström

Jörgen Johansson

Christina Stallings

Board of Directors

Sven Bergström
Chairman of the board

Lennart Hansson
Board member

Ulf Björklund
Board member

Yijing Sun Hultgren
Board member

Christina Stallings
Board member

Fredrik Almqvist
Board member

QureTech Bio Staff

Helén Fält
CEO

Annica Rönnbäck
COO

Mari Bonde
Senior Scientist,
Molecular biology

Souvik Sarkar
Senior Scientist, Chemisty

Hasan Tükenmez
Senior Scientist,
Molecular biology

Affiliated Scientists

Scott Hultgren
Professor

Fredrik Almqvist
Professor

Sven Bergström
Professor

Jörgen Johansson
Professor

Christina Stallings
Professor

Michael Caparon
Professor

Ana Flores-Mireles
Assistant Professor

Björn Olsen
Professor

Matthew Chapman
Professor

Jerry Pinkner
M.S.

Member of